Literature DB >> 28045580

Immune persistence after pertussis vaccination.

Zhiyun Chen1, Qiushui He1,2.   

Abstract

Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true infection rate is significantly higher than the reported incidence rate. An increased prevalence of pertussis in older populations has been found, mainly caused by waning immunity after vaccination. Vaccine-induced immunity differs due to variation in vaccine content, schedule and coverage. Protection following acellular pertussis vaccines has been suggested to wane faster than whole cell pertussis vaccines. However, long-term immune persistence of whole cell pertussis vaccines may be confounded by a progressive acquisition of natural immunity. The World Health Organization has recommended that a switch from whole cell to acellular pertussis vaccines for primary immunization in infants should only be considered if additional periodic boosters or maternal immunization can be ensured and sustained in the national immunization schedules. In this review, we present data on immune persistence after different pertussis vaccinations and compare the findings from countries with different vaccination strategies. Future aspects in serological studies are briefly discussed.

Entities:  

Keywords:  acellular pertussis vaccines; immune persistence; pertussis; vaccination; whole cell pertussis vaccines

Mesh:

Substances:

Year:  2017        PMID: 28045580      PMCID: PMC5404361          DOI: 10.1080/21645515.2016.1259780

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  125 in total

1.  Nomenclature for immune correlates of protection after vaccination.

Authors:  Stanley A Plotkin; Peter B Gilbert
Journal:  Clin Infect Dis       Date:  2012-03-20       Impact factor: 9.079

2.  Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.

Authors:  Hans O Hallander; Lennart Gustafsson; Margaretha Ljungman; Jann Storsaeter
Journal:  Vaccine       Date:  2005-07-01       Impact factor: 3.641

3.  [Bordetella pertussis infection].

Authors:  Angela Gentile
Journal:  Arch Argent Pediatr       Date:  2010-02       Impact factor: 0.635

4.  Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

Authors:  Lennart Gustafsson; Luc Hessel; Jann Storsaeter; Patrick Olin
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

5.  Induction of Bordetella pertussis-specific immune memory by DTPa vaccines.

Authors:  Sandra Morel; Philippe Denoël; Fabrice Godfroid; Caroline Cortvrindt; Nathalie Vanderheyde; Jan Poolman
Journal:  Vaccine       Date:  2011-03-05       Impact factor: 3.641

6.  Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.

Authors:  Françoise Vermeulen; Violette Dirix; Virginie Verscheure; Eliane Damis; Danièle Vermeylen; Camille Locht; Françoise Mascart
Journal:  Vaccine       Date:  2013-02-18       Impact factor: 3.641

7.  Effectiveness of maternal pertussis vaccination in England: an observational study.

Authors:  Gayatri Amirthalingam; Nick Andrews; Helen Campbell; Sonia Ribeiro; Edna Kara; Katherine Donegan; Norman K Fry; Elizabeth Miller; Mary Ramsay
Journal:  Lancet       Date:  2014-07-15       Impact factor: 79.321

8.  Epidemiology of pertussis in adolescents and adults in Turkey.

Authors:  A Karagul; D Ogunc; K Midilli; G Ongut; B Ozhak Baysan; L Donmez; D Daglar; M A Kuskucu; A Bingol; O Ozbudak; D Colak; F Gunseren
Journal:  Epidemiol Infect       Date:  2014-12-19       Impact factor: 4.434

9.  A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.

Authors:  Manoj Gambhir; Thomas A Clark; Simon Cauchemez; Sara Y Tartof; David L Swerdlow; Neil M Ferguson
Journal:  PLoS Comput Biol       Date:  2015-04-23       Impact factor: 4.475

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

View more
  15 in total

Review 1.  Prevention of pertussis: An unresolved problem.

Authors:  Susanna Esposito; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2018-07-24       Impact factor: 3.452

2.  Selective protection of murine cerebral Gi/o-proteins from inactivation by parenterally injected pertussis toxin.

Authors:  Salvador Castaneda Vega; Veronika Leiss; Roland Piekorz; Carsten Calaminus; Katja Pexa; Marta Vuozzo; Andreas M Schmid; Vasudharani Devanathan; Christian Kesenheimer; Bernd J Pichler; Sandra Beer-Hammer; Bernd Nürnberg
Journal:  J Mol Med (Berl)       Date:  2019-12-06       Impact factor: 4.599

3.  Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020.

Authors:  Enas Bahar; Daria Shamarina; Yan Sergerie; Piyali Mukherjee
Journal:  Infect Dis Ther       Date:  2022-07-06

4.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Differences in innate IFNγ and IL-17 responses to Bordetella pertussis between BALB/c and C57BL/6 mice: role of γδT cells, NK cells, and dendritic cells.

Authors:  Yung-Yi C Mosley; Fangjia Lu; Harm HogenEsch
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

6.  Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.

Authors:  Qinghong Meng; Lijun Li; Wei Shi; Qing Wang; Mingjie Ding; Yanqin Liu; Xiang Ma; Kaihu Yao
Journal:  BMC Pediatr       Date:  2018-12-05       Impact factor: 2.125

7.  Infection-acquired versus vaccine-acquired immunity in an SIRWS model.

Authors:  Tiffany Leung; Patricia T Campbell; Barry D Hughes; Federico Frascoli; James M McCaw
Journal:  Infect Dis Model       Date:  2018-06-15

8.  The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China.

Authors:  Qinghong Meng; Qinghui Qian; Li Li; Dandan Liu; Wei Gao; Lin Yuan; Kaihu Yao
Journal:  BMC Pediatr       Date:  2019-12-07       Impact factor: 2.125

9.  Immuno-proteomics analysis between OMV of vaccine and dominant wild type strains of Bordetella pertussis in Iran.

Authors:  Ali Badamchi; Fariborz Bahrami; Alireza Hadizadeh Tasbiti; Shamsi Yari; Morvarid Shafiei; Fereshteh Shahcheraghi; Seyed Davar Siadat
Journal:  Iran J Microbiol       Date:  2020-04

10.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.